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Background: Malaria in pregnancy (MiP) is a major public health problem in endemic areas of sub-Saharan Africa
and has important consequences on birth outcome. Because MiP is a complex phenomenon and malaria
epidemiology is rapidly changing, additional evidence is still required to understand how best to control malaria.
This study followed a prospective cohort of pregnant women who had access to intensive malaria screening and
prompt treatment to identify factors associated with increased risk of MiP and to analyse how various characteristics
of MiP affect delivery outcomes.
Methods: Between October 2006 and May 2009, 1,218 pregnant women were enrolled in a prospective cohort.
After an initial assessment, they were screened weekly for malaria. At delivery, blood smears were obtained from
the mother, placenta, cord and newborn. Multivariate analyses were performed to analyse the association between
mothers’ characteristics and malaria risk, as well as between MiP and birth outcome, length and weight at birth.
This study is a secondary analysis of a trial registered with ClinicalTrials.gov, number NCT00495508.
Results: Overall, 288/1,069 (27%) mothers had 345 peripheral malaria infections. The risk of peripheral malaria was
higher in mothers who were younger, infected with HIV, had less education, lived in rural areas or reported no bed
net use, whereas the risk of placental infection was associated with more frequent malaria infections and with
infection during late pregnancy. The risk of pre-term delivery and of miscarriage was increased in mothers infected
with HIV, living in rural areas and with MiP occurring within two weeks of delivery.
In adjusted analysis, birth weight but not length was reduced in babies of mothers exposed to MiP (−60g, 95%CI: -120
to 0 for at least one infection and -150 g, 95%CI: -280 to −20 for >1 infections).
Conclusions: In this study, the timing, parasitaemia level and number of peripherally-detected malaria infections, but not
the presence of fever, were associated with adverse birth outcomes. Hence, prompt malaria detection and treatment
should be offered to pregnant women regardless of symptoms or other preventive measures used during pregnancy,
and with increased focus on mothers living in remote areas.
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Despite numerous studies conducted over the last de-
cades, malaria in pregnancy (MiP) remains an important
public health problem that has proved difficult to tackle.
Many studies from areas with different malaria transmis-
sion patterns have investigated the consequences of MiP
on both maternal health and birth outcomes. While the
consequences of MiP on maternal health are dominated
by anaemia, data on malaria-related maternal mortality
are sparse [1]. For the foetus, the most commonly
reported adverse effect of MiP is an increased risk of low
birth weight (LBW) [2-5], which, in turn, is a significant
risk factor for both impaired development [6-8] and in-
fant mortality [9,10]. However, most of these studies used
only a single measurement point (from cross-sectional
surveys or at delivery) to identify MiP and, therefore, do
not capture the multiple factors that play a role over an
extended period of time.
While reliable assessment of MiP is critical to elucidat-
ing its impact on birth outcomes and infant health, it is
problematic because many factors (some of which are
difficult to fully capture) are relevant to a complete un-
derstanding. MiP may be either continuous or intermit-
tent, depending on a woman’s exposure to vectors, level
of immunity and possible co-infections (e.g. other mal-
aria species, HIV or helminths), and on the efficacy of
treatment and prevention interventions available to her.
Tools to measure parasite presence are limited by their
sensitivity and by how often women attend antenatal care
services; hence MiP is often only partially observed. To
more fully evaluate the impact of MiP on both maternal
and infant outcomes, investigations must consider mul-
tiple aspects of malaria infection, such as timing, fre-
quency, intensity and severity of the infections, as well as
the treatment provided.
Recent studies focused on one or a few features of mal-
aria, such as timing and/or frequency [11-15], or the ef-
fect of a single infection early in pregnancy (when weekly
screening was routinely provided throughout pregnancy
[13]), and have produced inconsistent results. Several in-
vestigations found that LBW risk was associated specific-
ally with malaria infections occurring in early pregnancy
[11,14,15]. In contrast, a study conducted in Benin re-
ported a higher risk of LBW associated with malaria in-
fection after six months of pregnancy [12], and data from
Thailand did not show a significantly lower birth weight
in newborns of mothers with a single treated malaria epi-
sode in the first trimester compared to newborns of
mothers without malaria infection [13]. Likewise, con-
flicting results have also been reported on the association
between the number of malaria infections and the risk of
LBW [11,14-16].
MiP is thought to affect birth outcomes through two
mechanisms, intrauterine growth restriction (IUGR) andpreterm delivery, which might - at least partially - explain
these discordant findings. It has been estimated that MiP
in settings with stable malaria transmission in Africa is
potentially responsible for up to 70% of IUGR and 36%
of preterm delivery [4]. The former has been consistently
associated with placental infection [17-24], while the lat-
ter appears to correlate with systemic manifestations of
malaria infection in the mother [25-27]. However, accur-
ate determination of gestational age is required to distin-
guish IUGR from preterm delivery—a determination that
is difficult to make in resource-constrained settings,
where tools such as ultrasound are rarely available. As a
result, evidence of the relative importance of IUGR ver-
sus preterm delivery due to MiP remains limited [28].
In recent years control of MiP has relied partly on inter-
mittent preventive treatment (IPT), with WHO currently
recommending at least two doses with sulphadoxine-
pyrimethamine (SP) [29]. However, growing resistance of
malaria parasites to SP in many regions [30,31], combined
with the changing epidemiology of malaria, indicate that
other prevention approaches must be strengthened. To
help fill the evidence gap regarding the impact of MiP on
delivery outcomes in accurately dated pregnancies, this
study reports on the findings from a prospective cohort of
pregnant women with access to weekly antenatal malaria
screening and prompt treatment.
Methods
Population and setting
The study was conducted in Mbarara district, southwest-
ern Uganda. This predominantly rural area lies at an alti-
tude of about 1,500 m above sea level and has moderate
levels of malaria transmission [32]. Between October 2006
and May 2009, 1,218 pregnant women with an estimated
gestational age ≥13 weeks were enrolled in a prospective
observational cohort. The first 1197 women in this cohort
screened for malaria with a positive rapid diagnostic test
(RDT) confirmed by a positive blood smear were invited
to participate in an additional study comparing the effi-
cacy and tolerance of artemether–lumefantrine with oral
quinine for the treatment of uncomplicated falciparum
malaria published elsewhere [33].
Clinical and monitoring procedures
At baseline, a comprehensive assessment of the pregnant
women’s socio-demographic characteristics and health
status was performed, including a medical and obstetrical
history, clinical and obstetric examination, ultrasound
evaluation, blood smear and hemoglobin measurement.
Estimated gestational age by was determined by ultra-
sound in all women enrolled in the study between week
16–20 of pregnancy (72% of the cohort). For the re-
maining mothers, i.e., those recruited after the 20th week
of gestation, we turned to a published model that predicts
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surements and calibrated it using the data from the 16–20
week group [34], and then used these results to predict
gestational age at delivery in the subset of mothers with-
out ultrasound (Additional file 1).
After this initial assessment, the mothers returned to
the clinic weekly for a clinical examination and malaria
RDT. In case of positive RDT, malarial infection was con-
firmed with a blood smear. Treatment of uncomplicated
falciparum malaria included a random allocation of
artemether-lumefantrine for three days or quinine for
seven days. Infections with only Plasmodium vivax were
treated with chloroquine. All women in the cohort re-
ceived standard supervised IPT with two doses of SP given
at intervals of one month or more during the second and
third trimesters, as well as iron and folate supplementa-
tion, antihelmintic treatment and insecticide-treated bed
nets (ITN). All treatments were provided free-of-charge.
At delivery, blood smears were obtained from the
mother, placenta, cord and newborn to test for the pres-
ence of Plasmodium and malaria pigment. Placental
histology was available only for a subset of the cohort
(n=260). Placental malaria cases were classified according
to the presence of parasitized erythrocytes, intervillous in-
flammation and haemozoin deposition [18,35]. Newborns
were given an initial standardized physical examination by
a medical officer, weighed to the nearest 10g using a SECA
mechanical type scale, and measured for length to the
nearest centimeter using a portable stadiometer (Shorr
productions, US). Infants delivered outside of a health fa-
cility were examined within 24 hours of birth by a study
medical officer.
Laboratory procedures
ParacheckW RDTs were performed using a finger-prick
blood sample and interpreted according to the manufac-
turer’s instructions. Thick and thin blood smears were
prepared and stained with Giemsa. Parasitaemia was cal-
culated by counting parasites against 200 white blood cells
(or 500, if nine parasites or fewer were counted against
200 white blood cells). Placental smears were taken by in-
cising a fresh placenta on the maternal surface halfway
between the cord and the periphery, and were then exam-
ined for the presence of parasites and pigment [35].
HIV testing and treatment was proposed to all partici-
pants and performed according to national guidelines
[36], which include cotrimoxazole prophylaxis for people
infected with HIV. Haemoglobin was measured from a
fingerprick sample by the Haemocue B-Haemoglobin
analyzer (Ängelholm, Sweden).
Definitions
Low birth weight was defined as <2,500 g measured within
24 hours of birth; preterm as newborn gestational age <37weeks at delivery; stillbirth as the delivery of a non-living
foetus ≥28 weeks gestation; and miscarriage as the delivery
of a non-viable foetus either at <28 weeks gestation or
weighing <500 g.
Statistical analysis
Malaria infection in pregnancy model
Various parameters of malaria exposure during pregnancy
were described and analysed for their temporal change
and for their association with maternal characteristics or
study interventions that may have affected MiP character-
istics. Peripheral malaria was defined as the occurrence of
a positive peripheral blood smear. After a treated malaria
episode, a subsequent episode was considered a recur-
rence only after a minimum of 14 days, with at least one
negative blood smear during this period [10]. Placental
malaria was defined as the detection by microscopy of any
parasite in a placental or cord blood smear.
The risk of peripheral malaria infection was analysed
with a mixed-effects Poisson model [37,38]. Since the oc-
currence of malaria before enrolment in the study could
not be observed (left censoring), the at-risk time period
was defined as the interval from study enrolment to deliv-
ery. Lead time bias was (partially) accounted for by includ-
ing the gestational age at enrolment as a covariate. Each
individual follow-up (from enrollment to delivery) was
split into intervals elapsing from one visit to another, and
the log duration of these intervals was included as an off-
set. Baseline risk was modeled using a spline function.
The level of parasitaemia (log transformed) was analysed
using a linear model. When more than one malaria epi-
sode was observed in a pregnancy, the maximal parasit-
aemia level recorded per episode was used as a dependent
variable. The presence of fever and the occurrence of pla-
cental malaria infection were analysed with logistic
models. In each model, maternal age, gravidity, HIV sta-
tus, education level, residency area (rural versus urban),
and gestational age at inclusion were considered as poten-
tial risk factors.
The number of IPT doses was introduced as a time-
dependent covariate in the model for peripheral malaria
risk. However, IPT was interrupted after the treatment of a
malaria infection, making the number of IPT doses an en-
dogenous variable [39]. Since data were censored at the first
malaria episode, only the relationship between the number
of IPT doses received up to the beginning of a time interval
and the risk of the first malaria episode during this time
interval was assessed (using a log-linear model).
Birth outcomes
The adverse outcomes evaluated in this study were still-
birth, preterm delivery, low birth weight and IUGR. IUGR
was defined as a birth weight below the 10th percentile of
the birth weight-for-gestational age. Type I (symmetric)
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according to whether the Rohrer index was above the
10th percentile of Rohrer index for gestational age or not.
United States population-based references were used as
standard [40,41]. The association of each outcome with
the various parameters of malaria exposure and with ma-
ternal characteristics were analysed separately for the full
cohort, the subset of mother--newborn pairs with no or
only one peripheral malaria infection, and the subset of
mother--newborn pairs with ultrasound assessment of
gestational age at baseline. Maternal age, education level
(no education, primary level or ≥secondary level), residence
area (rural versus urban), HIV status, number of clinic
follow-up visits before birth outcome (<4 versus ≥4), and
the newborn’s gender and gestational age at birth were in-
cluded in all models. Stillbirth was analysed as a binary
variable using a logistic model. Preterm delivery was
analysed with gestational age at birth included as a con-
tinuous or binary variable (gestational age <37 weeks)
using respectively a linear and logistic model. Weight and
length at birth were both considered as continuous vari-
ables and analysed with a linear model adjusted for gesta-
tional age at birth. Parasitaemia was categorized as none,
low (log parasitaemia ≤6 log parasites/μL) or high (>6 log
parasites/μL). Late malaria infection was defined as a per-
ipheral malaria infection occurring in the last two weeks
before delivery. To better understand the effect of malaria
infection timing independently of the enrolment timing,
the association between birth weight and gestational age at
infection (<15, 15-<20, 20-<24, ≥24 weeks) was analysed
with a linear model restricted to the subset of mothers with
no or only one malaria infection and with a gestational
age <15 weeks at enrolment.
All analyses were performed using the open source
statistical software R [42].
Ethical approval
Written informed consent for study participation was
obtained from all participants to the study. The study was
approved by the institutional review boards of Mbarara
University of Science and Technology, Uganda National
Council for Science and Technology, and France’s
“Comité de Protection des Personnes - Ile-de-France XI”.
This study was registered with ClinicalTrials.gov, number
NCT00495508.
Results
Study population characteristics
Of the 1,218 women enrolled in the cohort, 149 (12%)
were excluded from this analysis because they were lost
to follow-up before their pregnancy reached an outcome
(Figure 1). These excluded women were younger and
had shorter follow-up (p=0.0001). One maternal death
unrelated to malaria was observed (from sepsis five daysafter a caesarean section for obstructed labour in a
term pregnancy).
Characteristics of the 1,069 women included in this co-
hort are summarized in Table 1. Women with malaria were
enrolled somewhat later in their pregnancy than those with
no infection detected (Table 1). Most of the mothers deliv-
ered in a health facility (84% at the regional hospital and 3%
in a private clinic), with the remainder delivering at home.
Median gestational age at enrolment was 19 weeks (Inter
Quartile Range, IQR: 16–22) and median follow-up time
was 21 weeks (IQR: 16–24). Almost 50% of the mothers
reported the use of bed nets before the first visit. The mean
number of visits, equivalent to the mean number of screen-
ing tests, was high (18, IQR: 10–23) (Table 1).
Mothers without ultrasound assessment of gestational
age were more likely to live in remote rural areas (OR:
1.68, 95%CI: 1.21 - 2.31) and to be at a more advanced
stage of the pregnancy at enrolment (mean gestational at
enrolment was 23.5 weeks in mothers without ultrasound,
versus 18.5 weeks in those with ultrasound, p<0.001). Of
the 1,018 live births, 40 were excluded from the analysis
on birth weight and length (Figure 1).
Malaria exposure during pregnancy
Peripheral malaria infection
A total of 304 (28%) women had one or more malaria in-
fections detected by peripheral blood smear (all species in-
cluded) during follow-up visits, resulting in a total of 361
peripheral malaria infections (range: 1–4 malaria infec-
tions). Of the 242 (67%) infections recorded at inclusion,
all involved Plasmodium falciparum, with six mixed infec-
tions. The 111 subsequent malaria infections included
three mixed infections and 16 infections with non-
falciparum species. Of the 55 positive RDT results with
negative blood smear, 31 (52%) were observed at inclusion
but no detectable microscopic parasitaemia were identi-
fied, while 24 (48%) were observed later during the follow-
up period but with no previously documented infection.
Peripheral malaria infection was associated with fever
in only 16% of cases (n=62/361). The geometric mean
(range) of parasitaemia was 1669 (24 – 302 500) parasites/
μL. There were 23 women who had malaria and were not
in the trial. Of them, 13 (57%) received quinine, 6 (26%)
artemether-lumefantrine and the information was missing
for 4 patients (17%).
In multivariate analysis, the risk of peripheral malaria
was increased in mothers who were infected with HIV,
were younger, primigravidae, had a lower education level,
lived in rural areas and did not report bed net use at en-
rolment (Table 2, left column). In contrast, gestational age
at inclusion was negatively associated with the risk of mal-
aria infection. Compared to women who did not receive
any IPTp, those who received one or two doses had an al-
most five or ten-fold reduction, respectively, in malaria
Figure 1 Flow chart.
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0.14 - 0.30 and 0.10, 95%CI: 0.06 - 0.18). Women who ex-
perienced ≥2 malaria episodes were more likely to come
from a rural area (2.23, 95%CI: 1.01 - 4.89) and to have en-
rolled in the study later during their pregnancy (OR: 0.95,
95%CI: 0.91 - 1.00) than those who had only one episode.
Maximum parasitaemia was higher in women who were
infected with HIV, included late during gestation or
experienced recurrent malaria infections (Table 2, central
column). Women with recurrent infection showed no sig-
nificant difference in parasitaemia level between the first
and subsequent infections (p=0.7).
Placental malaria infection
Of the 665 placental smears available, parasites were ob-
served in 20 (3%) and pigment in 17 (2.5%) cases. The
presence of pigment was associated with detectable para-
sites in 12 (7%) of the cases. Most of the infected placentas
(17/20) came from mothers who had peripheral malaria
detected during their enrolment in the study; in the
remaining three women, no peripheral microscopic or
positive RDT was detected during pregnancy or at deliv-
ery. Conversely, almost all of the placental biopsies from
mothers without malaria detected during pregnancy had
no haemozoin deposition nor parasitized erythrocytes by
histology (72/79). All eight malaria infections in mothers
with detectable parasites, but no pigment in the placental
smear were observed during the third trimester. In ad-
justed analysis, the occurrence of a placental infectionwas associated with the number of peripheral malaria epi-
sodes, but not with parity (Table 2, right column). Similar
results were seen in the subset of women with only one
malaria infection (OR: 8.89, 95%CI: 1.07 - 74.21 for rural
versus urban residency; 1.14, 95%CI: 1.03 - 1.27 for each
additional week in gestational age, and 1.51, 95%CI: 1.03 -
2.22 for each log10 increase in parasitaemia level).
The association between the time since last malaria in-
fection and the risk of placental malaria was assessed in
a multivariate model restricted to women who experi-
enced at least one malaria infection. Risk of placental
malaria was negatively associated with the interval be-
tween the last peripheral infection and delivery (OR:
0.992, 95%CI: 0.985 - 0.998 per week) and positively as-
sociated with parasitaemia level (OR: 1.06, 95%CI: 1.02 -
1.10 per log10 increase). No microscopic placental
malaria was detected in women with a positive RDT, but
negative blood smear.
Delivery outcomes
Miscarriage and stillbirth
A total of 28 (3%) miscarriages and 22 (2%) stillbirths were
observed in the study cohort. In adjusted analysis, the risk
of miscarriage or stillbirth was significantly increased in
mothers who were HIV-infected, living in urban areas
or completed fewer follow-up visits (Table 3). Notably,
in a model adjusted for HIV status and area of resi-
dence, malaria within two weeks of delivery was associ-
ated with a twofold greater risk of stillbirth (OR: 2.15,
Table 1 Characteristics of the study population
No MiP MiP
Mother characteristics at
inclusion (n = 1069)
n=714 n=355
Median age, year (IQR) 24 (21 – 27) 22 (19 – 25)
Median gestational age,
week (IQR)
18 (15 – 20) 21 (17 – 28)
Residence, n (%)
Urban 429 (60) 118 (33)
Rural 285 (40) 236 (67)
Place of delivery, n (%)
Health facility 633 (88%) 291 (82%)
Home/transport 76 (11%) 62 (17%)
Education level, n (%)
No education 68 (10) 47 (13)
Primary 285 (40) 210 (59)
≥ Secondary 361 (50) 98 (28)
HIV status, n (%)
Negative 533 (74) 255 (71)
Positive 114 (16) 34 (10)
Unknown 67 (10) 66 (19)
Primigravid, n (%) 241 (34) 160 (45)
Delivery outcomes
Abortion 23 (3) 5 (1)
Stillbirth 13 (2) 9 (2)
Mean number of visits (IQR) 20 (17 – 23) 16 (10 – 22)
Newborn characteristics – liveborn singletons (n =967)
Gestational age at birth,
weeks (IQR)
40 (39 – 41) 40 (39 – 41)
Preterm delivery, n (%) 42 (7) 29 (9)
Median weight, kg (IQR) 3.11 (2.87 – 3.44) 3.095 (2.80 – 3.33)
Median length, cm (IQR) 50 (47 – 51) 49 (48 – 51)
Female, n (%) 344 (54) 183 (56)
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number of follow-up visits and the occurrence of malaria
infection late during gestation as covariates in the same
model because of their association with one another.
Pre-term delivery
Overall 65 (7%) live-born pre-term deliveries were ob-
served, with 45 (6%) occurring in the sub-group of
mothers with ultrasound estimation of gestational age.
In adjusted analysis of both the full cohort data and the
subset with ultrasound, the risk of pre-term delivery was
increased in women infected with HIV and in those with
fewer follow-up visits (Table 3). As with stillbirth, an as-
sociation between the risk of pre-term delivery and the
occurrence of a malaria infection within the last two
weeks of pregnancy was observed when the number offollow-up visits was dropped from the model, in both
the full cohort dataset and the ultrasound subset (ad-
justed OR were 1.91, 95%CI: 1.05 – 3.50 and 2.84, 95%
CI: 1.26 – 6.38, respectively).
Effect of malaria on gestation
In adjusted analysis, shortened gestation (because of mis-
carriage, stillbirth or pre-term delivery) was associated
with the occurrence of malaria infection within the last
two weeks of pregnancy (Figure 2). A borderline associ-
ation of shortened gestation with febrile malaria infection
associated was also found (p=0.06).
Weight and length at birth
In total, there were 57 (7%) infants with low birth weight,
39 (6%) with type II IUGR (asymmetric) and 89 (13%)
type I IUGR (symmetric). In analysis adjusted for gender
and for estimated gestational age at delivery, birth weight
was reduced in primiparae, in mothers with low educa-
tion level and in those who attended ≤4 follow-up visits
(Table 4). Greater birth weight was observed in mothers
with higher average hemoglobin level during pregnancy
(+30g, 95%CI: 10–50), however this association disap-
peared in multivariate analyses adjusted for MiP. Of the
various parameters of malaria exposure during preg-
nancy, all but placental malaria and symptomatic malaria
were associated with lower weight at birth (Figure 3).
However, the presence of malaria pigment in the placen-
tal smear was associated with reduced birth weight in
univariate analysis (−0.26, 95%CI: -0.49 to −0.032)
though not in adjusted analysis (p=0.2). Type I IUGR was
not associated with any aspect of malaria in pregnancy
(Additional file 2). By contrast, type II IUGR was in-
creased in mothers with more than one malaria episode
and with symptomatic malaria (Additional file 3). Median
gestational age at last malaria infection was 21 weeks
(19–22) in women with type I IUGR and 23 weeks
(22–24) in women with type II IUGR (p=0.08).
Analyses restricted to mothers with ultrasound-verified
gestational age, or to those with no or only one malaria in-
fection, found qualitatively similar associations, although
sometimes with only borderline significance (Figure 3).
Birth weight was not associated with the timing of the first
malaria infection in mothers with gestational age <15 weeks
at enrolment (p=0.8). This conclusion did not change when
the cut-offs used for gestational age at enrolment was var-
ied. No association was found between malaria exposure
during pregnancy and newborn length.
Discussion
The novel features of this cohort study are the frequent,
intensive malaria screenings (median of 21 screens per
pregnancy) and the provision of treatment based on the
presence of parasite in the blood rather than on
Table 2 Risk factors for peripheral malaria during pregnancy, parasitaemia and placental malaria
(multivariate analysis)
Peripheral malaria (rate ratio) Parasitaemia (log) Placental malaria (Odds ratio)
Maternal agea 0.97 (0.94 - 0.98) −0.01 (−0.04 to 0.01) 0.90 (0.80 - 1.02)
Education level
Primary level 0.76 (0.56 - 1.04) −0.10 (−0.40 to 0.20) 1.01 (0.17 - 5.81)
≥ secondary level 0.50 (0.35 - 0.72) −0.22 (−0.57 to 0.12) 2.05 (0.33 - 12.64)
Rural residence 1.97 (1.54 - 2.52) 0.04 (−0.18 to 0.27) 6.00 (1.29 - 28.02)
Primigravidae 1.31 (1.02 - 1.69) 0.08 (−0.17 0.33) 1.00 (0.33 – 3.00)
Use of bednet 0.71 (0.56 - 0.90) −0.08 (−0.30 to 0.14) 0.91 (0.30 - 2.77)
Gestational age at inclusionb 1.05 (1.03 - 1.07) 0.02 (0.00 to 0.04) 1.14 (1.05 - 1.24)
HIV status 0.92 (0.62 - 1.38) 0.42 (0.04 to 0.79) 2.68 (0.61 - 11.74)
# IPT doses
1 0.25 (0.17 – 0.35) ‐‐ ‐‐
2 0.10 (0.06 – 0.18) ‐‐ 0.92 (0.22 – 3.76)
# malaria episodes
1 ‐‐‐ ‐‐‐ 3.30 (0.69 -15.88)
≥2 ‐‐‐ 0.47 (0.19 to 0.74) 15.80 (2.77 - 90.27)
a.By 10 years; b. by week; IPT: intermittent preventive treatment.
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common in endemic Africa. Another strength of this
study is the accurate determination of gestational age for
the majority of pregnancies.
Our results suggest that peripheral malaria infections
during pregnancy, including those occurring late during
gestation, contribute significantly to perinatal morbidity.
Malaria infection at the end of pregnancy and those with
fever rather than other aspects of malaria exposure, were
associated more specifically with miscarriage or pre-term
delivery. A similar association between malaria infections
with fever and an increased risk of miscarriage has been
reported in mothers with a single malaria episode during
the first trimester of pregnancy [13]. Likewise, increased
infant mortality has been reported after symptomatic
malaria infections occurring at the end of the pregnancy
[10,43]. In low endemic areas, 80% of microscopically
detected infections become symptomatic if left untreated
[44]. Since women in this cohort were treated if they had
a positive blood smear, irrespective of whether they
showed symptoms, it seems likely that this early detec-
tion and treatment of asymptomatic infections preventedTable 3 Risk factors for adverse birth outcomes
(multivariate analysis)
Stillbirth/
abortion
Preterm delivery (<37 wks)
Full dataset Mother with US
Urban residency 2.60 (1.31 - 5.16) 1.38 (0.81 - 2.34) 1.49 (0.79 - 2.83)
HIV status 2.70 (1.19 - 6.11) 2.33 (1.17 - 4.64) 3.21 (1.43 - 7.22)
# follow-up visits 0.74 (0.70 - 0.79) 0.86 (0.83 - 0.90) 0.81 (0.76 - 0.87)higher rates of miscarriage and pre-term delivery.
Current WHO policy calls for “the administration of at
least two doses of SP during the second and third trimes-
ters of pregnancy” [45,46]. More effective protection dur-
ing late pregnancy is critical in low-endemic settings
such as Mbarara, and addition of an extra (third) SP dose
for all pregnant women rather than (as per current
WHO policy) only to HIV-infected women, or monthly
dosing, could provide more effective protection in all
pregnancies.
Adjusting for gestational age at birth, we found that
peripheral malaria infection during pregnancy was asso-
ciated with lower birth weight, and that this association
was consistently seen in both the full dataset and the
subset of mother with ultrasound examination. Further-
more, more severe birth weight impairment was ob-
served after multiple malaria infections and in malaria
infections with high parasitaemia, even when IPT and
bed net use was reported. These findings underscore the
importance of implementing efficacious prevention,
prompt diagnosis and highly effective anti-malarial treat-
ment during pregnancy [47].
In addition to primigravidity, a well-known risk factor
for MiP [1,4], it was found that low education level and
rural residence were independently associated with mal-
aria during pregnancy. These findings further support the
notion that it is essential to scale up malaria prevention ef-
forts in more isolated and deprived communities as re-
cently highlighted in a meta-analysis of datasets from 25
African countries [48]. A low number of antenatal visits
was also associated with reduced birth weight. The
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All mothers
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All mothers
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Mothers with a single episode
All mothers
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All mothers
Mothers with US
Mothers with a single episode
0 1 2 3 4 5 6
Risk of stillbirth / preterm delivery
Figure 2 Summary of the association between risk of stillbirth or preterm delivery and different parameters of malaria exposure
during pregnancy (odds ratio with 95% confidence intervals from analyses adjusted for maternal characteristics).
Table 4 Factors associated with weight and length at
birth (multivariate analysis, n = 967)
Weight at birth Length at birth
Newborn gendera −0.01 (−0.07 to 0.04) −0.03 (−0.44 to 0.38)
Maternal ageb 0.05 (−0.02 to 0.12) 0.32 (−0.19 to 0.83)
Education level
Primary level 0.06 (−0.03 to 0.15) −0.25 -0.92 0.42
≥ Secondary level 0.10 (0.00 to 0.20) −0.05 -0.75 0.65
Rural residency −0.01 (−0.07 to 0.05) −0.54 -0.97 -0.11
Primigravidae −0.12 (−0.19 to −0.05) −0.38 -0.88 0.11
HIV status 0.02 (−0.06 to 0.11) −0.20 -0.82 0.41
>4 follow-up visits 0.45 (−0.01 to 0.92) −2.42 -6.55 1.71
Gestational age at
birth (wks)
0.11 (0.09 to 0.12) 0.67 (0.56 to 0.77)
Any peripheral malaria −0.07 (−0.13 to 0.00) 0.17 (−0.30 to 0.64)
a Female versus male; b. by 10 years.
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improved control of malaria in pregnancy [45].
A limitation of this study was that documentation of
malaria infection began only after the first trimester of
pregnancy, resulting in left censored data. Women with
multiple infections were more likely to have been en-
rolled later during their gestation and, therefore, early
infections might have been missed. This could explain
the absence of association in this analysis between MiP
early during gestation and low birth weight, in contrast
to results from other studies [11,14,15]. Alternatively, ef-
fective treatment of a single infection may allow recov-
ery from infection and catch-up growth in utero.
Placental malaria has been shown to be a key inter-
mediate factor in the pathological pathway of malaria
[2,4,18,19]. However in our study, the proportion of pla-
cental infections (as determined from placental smears)
was low, which most likely reflects our study’s intensive
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Only 1 malaria
>1 malaria
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<=6 
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Placental malaria
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2 weeks of delivery
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All mothers
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Figure 3 Summary of the association between birth weight and different parameters of malaria exposure during pregnancy (mean
change with 95% confidence intervals from analyses adjusted for maternal characteristics).
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previously observed [20]. However, for placental malaria
diagnosis the sensitivity of parasite (rather than pigment)
on placenta smear is low, so the actual proportion of
placental infection might also have been underestimated
[49]. In a cohort study of women actively screened and
tested in the Gambia, the presence of pigment was
reported to better reflect past infection with malaria
[50], a finding which may explain why an association be-
tween low birth weight and the presence of pigment but
not with the presence of parasite in placental smear was
found in univariate analysis. Nevertheless, as the pla-
centa cannot be examined until delivery, hence until
after the adverse effect has already occurred, its utility
for clinical diagnosis and prevention remains limited.
On the other hand, peripheral parasitaemia, which was
associated with impaired delivery outcomes in this cohort,can be detected by frequent screening, so that prompt
treatment can be given and adverse effects of the infection
reduced. Since preventive efforts (IPT with SP and
insecticide-treated bed net) still leave a large proportion of
women with parasitaemia, taking the opportunity to screen
women when they present to antenatal care is a strategy
that should be considered. However, diagnostics for MiP re-
main problematic, since pregnant women often have low
levels of parasitaemia and require diagnostic tools with
greater sensitivity than microscopy (and good specificity)—
for example, the Loop-mediated isothermal amplification
(LAMP) [49,51]. As malaria prevalence decreases, the risk-
to-benefit ratio for providing IPT also reduces. Hence ef-
forts to determine the optimal number of screenings for
women in malaria endemic areas are also required.
In conclusion, this study shows that the timing, parasit-
aemia, symptoms and number of peripherally detected
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http://www.malariajournal.com/content/12/1/139malaria infections observed during pregnancy are associ-
ated with adverse outcomes. Prompt detection and treat-
ment with an effective anti-malarial should be offered,
irrespective of symptoms and use of other preventive mea-
sures in pregnancy. While frequent screening was associ-
ated with improved birth outcome, reaching mothers
living in remote areas to prevent late attendance and low
number of visits at antenatal care is essential, as they are
more likely to suffer from poor outcomes.
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